MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2025)
MapLight Therapeutics (MPLT) posted Cash from Financing Activities of $272.0 million for Q4 2025, up 5439200.0% sequentially from $5000.0 in Q4 2024, and up 5439200.0% YoY from N/an in Q4 2024.
MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Cash from Financing Activities for 2 years, with the latest figure at $272.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.42 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -6.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -207,909.22 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -273.15 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.24 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.18 Mn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 271.97 Mn |
| Dec 31, 2025 | 271.97 Mn |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |